Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review

Patients receiving ifosfamide as part of their cancer treatment are at risk for ifosfamide-related encephalopathy (IRE), a potentially serious adverse event affecting up to 60% of patients. Symptoms range from transient altered mental status to coma and death. Consensus regarding risk factors for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee Brink, Amanda, Bowe, Christi, Dains, Joyce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863121/
https://www.ncbi.nlm.nih.gov/pubmed/33604097
http://dx.doi.org/10.6004/jadpro.2020.11.4.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863121/
https://www.ncbi.nlm.nih.gov/pubmed/33604097
http://dx.doi.org/10.6004/jadpro.2020.11.4.4

Ejemplares similares